MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Autoimmune Movement Disorders: An Illustrative Case Series of 8 Patients.

    P. Singh, A. Gupta, A. Gupta (Delhi, India)

    Objective: The aim of this study is to describe the variability of presentations, etiology, management, follow up and outcome of autoimmune encephalitis, a potentially reversible…
  • 2024 International Congress

    Can We Rid Uganda of the Societal Myth That Parkinson’s Disease Is Witchcraft?

    S. Klingelhofer, H. Tamale, G. Mogan (Tillamook, USA)

    Objective: Educate rural Ugandans that Parkinson’s Disease (PD) is a scientific disorder, not contagious or the result of anything mystical Background: People with PD (PWP)…
  • 2024 International Congress

    Delayed movement disorders after usage of desomorphine-“crocodile”. Clinical case.

    G. Ilina, D. Khasanova, Z. Zalyalova, A. Katok (Kazan, Russian Federation)

    Objective: To study the clinical and neuroimaging features of a patient with a long-term use (more than 10 years) of desomorphine in the anamnesis. Background:…
  • 2024 International Congress

    Movement Disorders in Autoimmune Encephalitis: A case series of 11 cases.

    G. Costa, C. Del Prado, A. Marin, I. Apaza, M. Bendersky, C. Simison, P. Hernandez, F. Echeverria, T. Arakaki, S. Rodriguez Quiroga, N. Garretto (CABA Buenos Aires, Argentina)

    Objective: Describe abnormal movements associated with autoimmune encephalopathies (AIE) Background: Movement disorders are a hallmark feature of autoimmune encephalitis (AIE), playing a pivotal role in…
  • 2024 International Congress

    Instrument-supported Gait Analysis Characterizes Gait Domain Changes in Patients with Suspected Normal Pressure Hydrocephalus – a Retrospective Study

    C. Semmler (Cologne, Germany)

    Objective: This study aimed at further characterizing the gait of patients with clinically suspected Normal Pressure Hydrocephalus (NPH) by investigating changes in several gait domains…
  • 2024 International Congress

    7year followup of Asia’s first case of sporadic ATP6AP2 Mutation: α-synucleinopathy or tauopathy?

    K. Shukla, N. Sawal, A. Prasad (Mohali, India)

    Objective: ATP6AP2 mutation, previously described in literature to cause early onset Parkinson’s disease (PD) with atypical signs, evolved into frontotemporal lobar degeneration in a 7year…
  • 2024 International Congress

    A Risk of Thromboembolic Complications In Patients With Parkinson’s Disease

    P. Lisewski, B. Lisewska, N. Słomka, M. Wasilewska, D. Rość (Bydgoszcz, Poland)

    Objective: A small number of reports refer to studies assessing the risk of thromboembolic complications in patients with PD in the form of a stroke,…
  • 2024 International Congress

    DPPX Autoimmune Encephalitis Associated with Severe Multifocal Dystonia.

    E. Roddy, E. Gentry, P. Hedera, V. Holiday, D. Robertson (LOUISVILLE, USA)

    Objective: To describe a novel motor phenomenology in an individual diagnosed with anti-DPPX encephalitis at our institution and to compare it with previously known phenotypic…
  • 2024 International Congress

    Genome-wide Assessment of Homozygosity in Parkinson’s Disease Across Diverse Ancestral Population

    K. Step, C. Hernandez Astudillo, E. Eltaraifee, Z-H. Fang, A. Hernández-Medrano, P-J. Kung, M. Ostrožovičová, A. Zirra, I. Sarmiento, S. Bandres-Ciga (Cape Town, South Africa)

    Objective: Our objective is to undertake the most extensive screening of the impact of homozygosity in Parkinson's disease (PD) etiology across diverse populations. We aim…
  • 2024 International Congress

    Genetic Study of polymorphism of cytokines in Parkinson’s disease.

    S. Frikha, O. Ben Othmen, S. Fezai, A. Achouri, M. Ben Mahmoud, S. Fray, H. Jamoussi, M. Fredj, N. Ben Ali (Tunis, Tunisia)

    Objective: The aim of our study was to conduct a cohort that demonstrates genetic variations in cytokines genes involved in the physiopathology, the development and…
  • « Previous Page
  • 1
  • …
  • 292
  • 293
  • 294
  • 295
  • 296
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley